Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-05T15:52:18.726Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Germicides in the Home and the Healthcare Setting Is There a Relationship Between Germicide Use and Antibiotic Resistance?

Published online by Cambridge University Press:  21 June 2016

David J. Weber  and
William A. Rutala
David J. Weber
Affiliation:
Division of Infectious Disease, University of North Carolina (UNC) School of Medicine, and the Department of Hospital Epidemiology, UNC Health Care System, Chapel Hill, North Carolina
William A. Rutala*
Affiliation:
Division of Infectious Disease, University of North Carolina (UNC) School of Medicine, and the Department of Hospital Epidemiology, UNC Health Care System, Chapel Hill, North Carolina
*
CB #7030 Bioinformatics Building, 130 Mason Farm Road, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030, ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

Background.

The spread of antibiotic-resistant pathogens represents an increasing threat in healthcare facilities. Concern has been expressed that the use of surface disinfectants and antiseptics may select for antibiotic-resistant pathogens.

Objective.

To review the scientific literature on whether there is a link between use of germicides (ie, disinfectants and antiseptics) and bacterial resistance to antibiotics. In addition, we will review whether antibiotic-resistant bacteria exhibit altered susceptibility to germicides that are recommended for use as disinfectants or antiseptics.

Design.

A review of the appropriate scientific literature.

Results.

In the laboratory, it has been possible to develop bacterial mutants with reduced susceptibility to disinfectants and antiseptics that also demonstrate decreased susceptibility to antibiotics. However, the antibiotic resistance described was not clinically relevant because the test organism was rarely a human pathogen, the altered level of antimicrobial susceptibility was within achievable serum levels for the antibiotic, or the antibiotic tested was not clinically used to treat the study pathogen. Similarly, wild-type strains with reduced susceptibility to disinfectants (principally, quaternary ammonium compounds) and antiseptics (principally, triclosan) have been reported. However, because the concentration of disinfectants used in the healthcare setting greatly exceeds the concentration required to kill strains with reduced susceptibility to disinfectants, the clinical relevance of these observations is questionable.

Conclusion.

To date, there is no evidence that using recommended antiseptics or disinfectants selects for antibiotic-resistant organisms in nature. Disinfectants and antiseptics should be used when there are scientific studies demonstrating benefit or when there is a strong theoretical rationale for using germicides.

Type
Review Articles
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 10 , October 2006 , pp. 1107 - 1119
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gold, HS, Moellering, RC. Drug therapy: antimicrobial-drug resistance. New Engl J Med 1996; 335:1445–1453.Google Scholar
2. Castiglia, M, Smego, RA. The global problem of antimicrobial resistance [published correction appears in J Am Pharm Assoc (Wash) 1997; NS37: 484]. J Am Pharm Assoc (Wash) 1997; NS37:383–387.Google Scholar
3. Tenover, FC. Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin Infect Dis 2001; 33(Suppl 3):S108–S115.Google Scholar
4. Levy, SB. Antibiotic resistance: consequences of inaction. Clin Infect Dis 2001; 33(Suppl 3):S124–S129.CrossRefGoogle ScholarPubMed
5. Sefton, AM. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium. Drugs 2002; 62:557–566.CrossRefGoogle ScholarPubMed
6. Levy, SB, Marshall, R. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004; 10(Suppl 12):S122–S129.CrossRefGoogle ScholarPubMed
7. Furuya, EY, Lowy, FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 2006; 4:36–45.Google Scholar
8. Tan, TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcomes. Curr Opin Infect Dis 2003; 16:271–277.Google Scholar
9. Pallares, R, Fenoll, A, Linares, J. The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones. Int J Antimicrob Agents 2003; 22(Suppl 1):S15–S24.CrossRefGoogle ScholarPubMed
10. Jacobs, MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med 2004; 117(Suppl 3A):3S–15S.Google Scholar
11. Lynch, JP, Zhanel, CG. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy. Semin Respir Crit Care Med 2005; 26:575–616.CrossRefGoogle ScholarPubMed
12. Klugman, KP, Lonks, JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 2005; 11:802–807.Google Scholar
13. Dye, C, Williams, BG, Espinal, MA, Raviglione, MC. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 2002; 295:2042–2046.Google Scholar
14. Dye, C, Espinal, MA, Watt, CJ, Mbiaga, C, Williams, BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185:1197–1202.Google Scholar
15. Espinal, MA. The global situation of MDR-TB. Tuberculosis (Edinb) 2003; 83:44–51.Google Scholar
16. Mitchison, DA. Drug resistance in tuberculosis. Eur Respir J 2005; 25:376–379.CrossRefGoogle ScholarPubMed
17. Ormerod, LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 2005; 73-74:17–24.Google Scholar
18. Lind, I. Antimicrobial resistance in Neisseria gonorrhoeae . Clin Infect Dis 1997; 24(Suppl 1):S93–S97.Google Scholar
19. Ison, CA, Dillon, J-A, Tapsall, JW. The epidemiology of global resistance among Neisseria gonorrhoeae and Hemophilus ducreyi . Lancet 1998; 351(Suppl 3):8–11.Google Scholar
20. Fox, KK, Knapp, JS. Antimicrobial resistance in Neisseria gonorrhoeae . Curr Opin Urol 1999; 9:65–70.Google Scholar
21. Ghanem, KG, Giles, JA, Zenilman, JM. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic. Infect Dis Clin North Am 2005; 19:351–365.CrossRefGoogle ScholarPubMed
22. Parr, CM. Antimicrobial drug resistance in Salmonella enterica . Curr Opin infect Dis 2003; 16:467–472.Google Scholar
23. Su, L-H, Chiu, C-H, Chu, C, Ou, JT. Antimicrobial resistance in non-typhoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004; 39:546–551.CrossRefGoogle Scholar
24. Fluit, AC. Towards more virulent and antibiotic-resistant Salmonella? FEMS Immunol Med Microbiol 2005; 43:1–11.Google Scholar
25. Weinberger, M, Keller, N. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis 2005; 18:513–521.Google Scholar
26. Vandenesch, F, Naimi, T, Enright, MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infec Dis 2003; 9:978–984.Google Scholar
27. Fridkin, SK, Hageman, JC, Morrison, M, et al. Methicillin-resistant Staphylococcus aureus in three communities. New Engl J Med 2005; 352:1436–1444.Google Scholar
28. Zetola, N, Francis, JS, Neumberger, EL, Bishai, W. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5:275–286.Google Scholar
29. Farr, BM. Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2004; 17:317–322.Google Scholar
30. Gould, IM. The clinical significance of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2005; 61:277–282.Google Scholar
31. Appelbaum, PC. MRSA-the tip of the iceberg. Clin Microbiol Infect 2006; 12(Suppl 2):3–10.Google Scholar
32. Chavers, LS, Moser, SA, Benjamin, WH, et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect 2003; 53:159–171.Google Scholar
33. Patel, R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51(Suppl S3):iii13–iii21.Google Scholar
34. Mascini, EM, Bonten, MJ. Vancomycin-resistant enterococci: consequences for therapy and infection control. Clin Microbiol Infect 2005; 11(Suppl 4):43–56.Google Scholar
35. Zirakzadeh, A, Patel, R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006; 81:529–536.Google Scholar
36. Couvalin, P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006; 42(Suppl 1):S25–S34.CrossRefGoogle Scholar
37. Colodner, R. Extended-spectrum β-lactamases: a challenge for clinical microbiologists and infection control specialists. Am J Infect Control 2005; 33:104–107.Google Scholar
38. Jacoby, GA, Munoz-Price, LS. The new β-lactamases. New Engl J Med 2005; 352:380–391.Google Scholar
39. Paterson, DL, Bonomo, RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657–686.Google Scholar
40. Giamarellou, H. Multidrug resistance in gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 2005; 11(Suppl 4):1–16.Google Scholar
41. Rossolini, GM, Mantengoli, F. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa . Clin Microbiol Infect 2005; 11(Suppl 4):17–32.CrossRefGoogle ScholarPubMed
42. Navon-Venezia, S, Ben-Ami, R, Carmeli, Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 2005; 18:306–313.Google Scholar
43. Obritsch, MD, Fish, DN, MacLaren, R, Jung, R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005; 25:1353–1364.Google Scholar
44. Hanlon, GW. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol 2005; 41:375–378.CrossRefGoogle Scholar
45. Murray, CK, Hospenthal, DR. Treatment of multidrug resistant Acinetobacter . Curr Opin Infect Dis 2005; 18:502–506.Google Scholar
46. Hamilton, CD. Recognizing and preventing the spread of drug-resistant Mycobacterium tuberculosis . Sem Infect Control 2001; 1:202–209.Google Scholar
47. Segal-Maurer, S, Urban, C, Rahal, JJ Jr. Current perspectives on multidrug-resistant bacteria. Infect Dis Clin North Am 1996; 10:939–957.Google Scholar
48. Shales, DM, Gerding, DN, John, JF, et al. Society of Healthcare Epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584–599.Google Scholar
49. Levy, SB. Antimicrobial resistance: bacteria on the defence. BMJ 1998; 317:612–613.Google Scholar
50. Levy, SB. Antimicrobial and antiseptic resistance: impact on the public health. Pediatr Infect Dis J 2000; 19(Suppl 10):S120–S122.Google Scholar
51. Levy, SB. Antibacterial household products: cause for concern. Emerg Infect Dis 2001; 7(Suppl 3):512–515.Google Scholar
52. Levy, SB. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 2002; 49:25–30.Google Scholar
53. Fraise, AP. Biocide abuse and antimicrobial resistance—a cause for concern? J Antimicrob Chemother 2002; 49:11–12.CrossRefGoogle ScholarPubMed
54. Russell, AD. Biocides and pharmacologically active drugs as residues and in the environment: is there a correlation with antibiotic resistance? Am J Infect Control 2002; 30:495–498.CrossRefGoogle Scholar
55. Russell, AD. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 2002; 92(Suppl): 121S–135S.CrossRefGoogle ScholarPubMed
56. Gilbert, P, McBain, AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 2003; 16:189–208.CrossRefGoogle ScholarPubMed
57. Rutala, WA, Weber, DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis 2004; 39:702–709.Google Scholar
58. Rutala, WA, Weber, DJ. CDC Guideline for disinfection and sterilization in healthcare facilities. The Healthcare Infection Control Practices Advisory Committee. MMWR Morb Mortal Wkly Rep. In press.Google Scholar
59. Boyce, JM, Pittet, D. Guideline for hand hygiene in health-care settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002; 51(RR-16):1–45.Google Scholar
60. Rutala, WA. APIC guidelines for infection control practice. Am J Infect Control 1996; 24:313–342.Google Scholar
61. Turnidge, JD, Jorgensen, JH. Antimicrobial susceptibility testing: general considerations. In: Murray, PR, ed. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press; 1999:1469–1473.Google Scholar
62. NCCLS. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. NCCLS document M100-S12. Wayne, PA: NCCLS; 2002.Google Scholar
63. Russell, AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 1999; 43(Suppl):S57–S68.Google Scholar
64. Gerba, CP, Rusin, P. Relationship between the use of antiseptics and disinfectants and the development of antimicrobial resistance. In: Rutala, WA, ed. Proceedings of the Conference on Disinfection, Antisepsis and Sterilization: Practices and Challenges for the New Millennium. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001:187–194.Google Scholar
65. Heinzel, M. Phenomena of biocide resistance in microorganisms. Int Biodeterior Biodegrad 1998; 41:225–234.Google Scholar
66. Hawkey, PM. Mechanisms of resistance of antibiotics. Intensive Care Med 2000; 26(Suppl):S9–S13.CrossRefGoogle Scholar
67. Hogan, D, Kolter, R. Why are bacteria refractory to antimicrobials? Curr Opin Microbiol 2002; 5:472–477.Google Scholar
68. Normark, BH, Normark, S. Evolution and spread of antibiotic resistance. J Intern Med 2002; 252:91–106.Google Scholar
69. Azucena, E, Mobashery, S. Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. Drug Resist Updat 2001; 4:106–117.Google Scholar
70. Philippon, A, Arlet, G, Jacoby, GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002; 46:1–11.Google Scholar
71. Chambers, HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J Infect Dis 1999; 179(Suppl 2):S353–S359.Google Scholar
72. Chambers, HF. Methicillin-resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10:781–791.Google Scholar
73. Shortridge, VD, Flamm, RK, Ramer, N, Beyer, J, Tanaka, SK. Novel mechanism of macrolide resistance in Streptococcus pneumoniae . Diagn Microbiol Infect Dis 1996; 26:73–78.CrossRefGoogle ScholarPubMed
74. Shortridge, VD, Doern, GV, Brueggemann, AB, Beyer, JM, Flamm, RK. Prevalence of macrolide resistance mechanisms in isolates from a multicenter antibiotic resistance prevalence study conducted in the United States in 1994-1995. Clin Infect Dis 1999; 29:1186–1188.Google Scholar
75. Berger-Bachi, B. Genetic basis of methicillin resistance in Staphylococcus aureus . CMLS, Cell Mol Life Sci 1999; 56:764–770.Google Scholar
76. Huovinen, P. Increases in rates of resistance to trimethoprim. Clin Infect Dis 1997; 24(Suppl 1):S63–S66.Google Scholar
77. Sutcliffe, J, Tait-Kamradt, A, Wondrack, L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40:1817–1824.Google Scholar
78. Nikaido, H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 2001; 12:215–223.Google Scholar
79. Levy, SB. Active efflux, a common mechanism for biocide and antibiotic resistance. J Appl Microbiol 2002; 92(Suppl):65S–71S.Google Scholar
80. Huovinen, P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis 2001; 32:1608–1614.Google Scholar
81. Acar, JF, Goldstein, FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997; 24(Suppl 1):S67–S73.Google Scholar
82. Thornsberry, C, Sahm, DF, Kelly, LJ, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST surveillance program, 1999-2000. Clin Infect Dis 2002; 34(Suppl 1):S4–S16.Google Scholar
83. Hoban, DJ, Doern, GV, Fluit, AC, Roussel-Delvallez, M, Jones, RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S81–S83.Google Scholar
84. Diekema, DJ, Pfaller, MA, Schmitz, FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S114–S132.CrossRefGoogle ScholarPubMed
85. Low, DE, Keller, N, Barth, A, Jones, RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S133–S145.Google Scholar
86. Russell, AD. Mechanisms of bacterial resistance to biocides. Int Biodeterior Biodegrad 1995; 36:247–265.Google Scholar
87. Russell, AD. Mechanisms of bacterial resistance to antibiotics and biocides. Prog Med Chem 1998; 35:133–197.Google Scholar
88. Jones, RD. Bacterial resistance and topical antimicrobial wash products. Am J Infect Control 1999; 27:351–363.Google Scholar
89. McDonnell, G, Russell, AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12:147–179.Google Scholar
90. Russell, AD. Mechanisms of bacterial insusceptibility to biocides. Am J Infect Control 2001; 29:259–261.Google Scholar
91. Poole, K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol 2002; 92(Suppl):55S–64S.Google Scholar
92. Bloomfield, SF. Significance of biocide usage and antimicrobial resistance in domiciliary environments. J Appl Microbiol 2002; 92(Suppl): 144S–157S.Google Scholar
93. Russell, AD. Do biocides select for antibiotic resistance? J Pharm Pharmacol 2000; 52:227–233.CrossRefGoogle ScholarPubMed
94. Maillard, J-Y. Bacterial target sites for biocide action. J Appl Microbiol 2002; 92(Suppl):16S–27S.Google Scholar
95. Rutala, WA, Weber, DJ. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 2001; 32:1348–1356.Google Scholar
96. Barbee, SL, Weber, DJ, Sobsey, MD, Rutala, WA. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization. Gastrointest Endosc 1999; 49:605–611.Google Scholar
97. Russell, AD. The role of plasmids in bacterial resistance to antiseptics, disinfectants and preservatives. J Hosp Infect 1985; 6:9–19.Google Scholar
98. Russell, AD. Plasmids and bacterial resistance to biocides. J Appl Microbiol 1997; 82:155–165.Google Scholar
99. al-Masaudi, SB, Day, MJ, Russell, AD. Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants. J Appl Microbiol 1988; 65:329–337.Google ScholarPubMed
100. al-Masaudi, SB, Russell, AD, Day, MJ. Comparative sensitivity to antibiotics and biocides of methicillin-resistant Staphylococcus aureus strains from Saudi Arabia and Great Britain. J Appl Bacteriol 1991; 71:331–338.Google Scholar
101. Alqurashi, AM, Day, MJ, Russell, AD. Susceptibility of some strains of enterococci and streptococci to antibiotics and biocides. J Antimicrob Chemother 1996; 38:745.Google Scholar
102. Kucken, D, Feucht, H-H, Kaulfers, P-M. Association of qacE and qacEδl with multiple resistance to antibiotics and antiseptics in clinical isolates of gram-negative bacteria. FEMS Microbiol Lett 2000; 183:95–98.Google Scholar
103. Irizarry, L, Merlin, T, Rupp, J, Griffith, J. Reduced susceptibility of methicillin-resistant Staphylococcus aureus to cetylpyridinium chloride and Chlorhexidine. Chemotherapy 1996; 42:248–252.Google Scholar
104. Bradley, CR, Fraise, AP. Heat and chemical resistance of enterococci. J Hosp Infect 1996; 34:191–196.Google Scholar
105. Koljalg, S, Naaber, P, Mikelsaar, M. Antibiotic resistance as an indicator of bacterial Chlorhexidine susceptibility. J Hosp Infect 2002; 51:106–113.Google Scholar
106. Sakagami, Y, Kajimura, K. Bactericidal activities of disinfectants against vancomycin-resistant enterococci. J Hosp Infect 2002; 50:140–144.Google Scholar
107. Anderson, RL, Carr, JH, Bond, WW, Favero, MS. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol 1997; 18:195–199.Google Scholar
108. Rutala, WA, Stiegel, NM, Sarubbi, FA, Weber, DJ. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Control Hosp Epidemiol 1997; 18:417–421.Google Scholar
109. Haines, KA, Klein, DA, McDonnell, G, Pretzer, D. Could antibiotic-resistant pathogens be cross-resistant to hard-surface disinfectants? Am J Infect Control 1997; 25:439–441.Google Scholar
110. Rutala, WA, Barbee, SL, Aguiar, NC, Sobsey, MD, Weber, DJ. Antimicrobial activity of home disinfectants and natural products against potential human pathogens. Infect Control Hosp Epidemiol 2000; 21:33–38.Google Scholar
111. Moken, MC, McMurray, LM, Levy, SB. Selection of multiple-antibiotic-resistant (MAR) mutants of Escherichia coli by using the disinfectant pine oil: roles of mar and acrAB loci. Antimicrob Agents Chemother 1997; 41:2770–2772.Google Scholar
112. Russell, AD, Tattawasart, U, Maillard, J-Y, Furr, JR. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother 1998; 42:2151.Google Scholar
113. Akimitsu, N, Hamamoto, H, Inoue, R, et al. Increase in resistance of methicillin-resistant Staphylococcus aureus to β-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999; 43:3042–3043.Google Scholar
114. Tattawasart, U, Maillard, JY, Furr, JR, Russell, AD. Development of resistance to Chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999; 42:219–229.Google Scholar
115. Brown, MRW, Tomlinson, E. Sensitivity of Pseudomonas aeruginosa envelope mutants to alkylbenzyldimethylammonium chlorides. J Pharm Sci 1979; 68:146–149.Google Scholar
116. McMurry, LM, McDermott, PF, Levy, SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999; 43:711–713.Google Scholar
117. Chuanchuen, R, Beinlich, K, Hoang, TT, Becher, A, Karkhoff-Schweizer, RR, Schweizer, HP. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001; 45:428–432.Google Scholar
118. George, AM. Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microbiol Lett 1996; 139:1–10.Google Scholar
119. Price, CTD, Singh, VK, Jayaswal, RK, Wilkinson, BJ, Gustafson, JE. Pine oil cleaner-resistant Staphylococcus aureus: reduced susceptibility to vancomycin and oxacillin and involvement of SigB. Appl Environ Microbiol 2002; 68:5417–5421.Google Scholar
120. Adair, FW, Geftic, SG, Geizer, J. Resistance of Pseudomonas to quaternary ammonium compounds. Appl Microbiol 1971; 21:1058–1063.Google Scholar
121. Stickler, DJ. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol 2002; 92(Suppl):163S–170S.Google Scholar
122. Gupta, A, Matsui, K, Lo, J-F, Silver, S. Molecular basis for resistance to silver cations in Salmonella . Nat Med 1999; 5:183–188.Google Scholar
123. Cooksey, DA. Characterization of a copper resistance plasmid conserved in copper-resistant strains of Pseudomonas syringae pv. tomato . Appl Environ Microbiol 1987; 53:454–456.Google Scholar
124. Tennent, JM, Lyon, BR, Midgley, M, et al. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus . J Gen Microbiol 1989; 135:1–10.Google Scholar
125. Littlejohn, TG, DiBerardino, D, Messerotti, LJ, Spiers, SJ, Skurray, RA. Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus . Gene 1991; 101:59–66.Google Scholar
126. Littlejohn, TG, Paulsen, IT, Gillespie, MT, et al. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus . FEMS Microbiol Lett 1992; 95:259–266.Google Scholar
127. Behr, H, Reverdy, ME, Mabilat, C, Freney, J, Fleurette, J. Relationship between the minimum inhibitory concentrations of five antiseptics and the presence of qacA gene in Staphylococcus aureus [in French]. Pathol Biol (Paris) 1994; 42:438–444.Google Scholar
128. Leelaporn, A, Paulsen, IT, Tennent, JM, Littlejohn, TG, Skurray, RA. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J Med Microbiol 1994; 40:214–222.Google Scholar
129. Bhargava, HN, Leonard, PA. Triclosan: applications and safety. Am J Infect Control 1996; 24:209–18.Google Scholar
130. Jones, RD, Jampani, HB, Newman, JL, Lee, AS. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 2000; 28:184–196.Google Scholar
131. McMurry, LM, Oethinger, M, Levy, SB. Triclosan targets lipid synthesis. Nature 1998; 394:531–532.Google Scholar
132. Heath, RJ, Yu, Y-T, Shapiro, MA, Olson, E, Rock, CO. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem 1998; 273:30316–30320.Google Scholar
133. Heath, RJ, Rubin, JR, Holland, DR, Zhang, E, Snow, ME, Rock, CO. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 1999;274:11110–11114.Google Scholar
134. Levy, CO, Roujeinikova, A, Sedelnikova, S, et al. Molecular basis of triclosan activity. Nature 1999; 398:383–384.Google Scholar
135. Schweizer, HP. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 2001; 202:1–7.Google Scholar
136. Heath, RJ, White, SW, Rock, CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 2001; 40:467–497.Google Scholar
137. Heath, RJ, Li, J, Roland, GE, Rock, CO. Inhibition of Staphylococcus aureus NADPH-dependent enoylacyl carrier protein reductase by triclosan and hexachlorophene. J Biol Chem 2000; 275:4654–4659.Google Scholar
138. Heath, RJ, Rock, CO. A triclosan-resistant bacterial enzyme. Nature 2000; 406:145–146.Google Scholar
139. Hoang, TT, Schweizer, HP. Characterization of Pseudomonas aeruginosa enoylacyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol 1999; 181:5489–5497.Google Scholar
140. Parikh, SL, Xiao, G, Tonge, PJ. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 2000; 39:7645–7650.Google Scholar
141. Bamber, AI, Neal, TJ. An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus . J Hosp Infect 1999; 41:107–109.Google Scholar
142. Suller, MTE, Russell, AD. Triclosan and antibiotic resistance in Staphylococcus aureus . J Antimicrob Chemother 2000; 46:11–18.Google Scholar
143. McMurry, LM, Oethinger, M, Levy, SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli . FEMS Microbiol Lett 1998; 166:305–309.Google Scholar
144. Schweizer, HP. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob Agents Chemother 1998; 42:394–398.Google Scholar
145. Barakate, MS, Yang, Y-X, Foo, S-H, et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000; 44:19–26.Google Scholar
146. Irish, D, Eltringham, I, Teall, A, et al. Control of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J Hosp Infect 1998; 39:19–26.Google Scholar
147. Zafar, AB, Gaydos, LA, Furlong, WB, Nguyen, MH, Mennonna, PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile . Am J Infect Control 1998; 26:588–593.Google Scholar
148. Daughton, CG, Ternes, TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 1999; 107(Suppl 6):907–938.Google Scholar
149. Perencevich, EN, Wong, MT, Harris, AD. National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control 2001; 29:281–283.Google Scholar
150. Braid, JJ, Wale, MCJ. The antibacterial activity of triclosan-impregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus, and Shewanella putrifaciens in conditions simulating domestic use. J Antimicrob Chemother 2002; 49:87–94.Google Scholar
151. Aiello, AE, Marshall, B, Levy, SB, Della-Latta, P, Larson, E. Relationship between triclosan and susceptibilities of bacteria from hands in the community. Antimicrob Agents Chemother 2004; 48:2973–2979.Google Scholar
152. Aiella, AE, Marshall, B, Levy, SB, Della-Latta, P, Lin, SX, Larson, E. Antibacterial cleaning products and drug resistance. Emerg Infect Dis 2005; 11:1565–1570.Google Scholar
153. Association for Professionals in Infection Control and Epidemiology. The use of antimicrobial products. APIC 1997 Guidelines Committee position statement. APIC News 1997; November/December:13.Google Scholar
154. Centers for Disease Control and Prevention. Monitoring hospital-acquired infections to promote patient safety—United States, 1990-1999 [published correction appears in MMWR Morb Mortal Wkly Rep 2000; 49:189-190]. MMWR Morb Mortal Wkly Rep 2000; 49:149–153.Google Scholar
155. Jasny, BR, Bloom, FE. It's not rocket science—but it can save lives. Science 1998; 280:1507.Google Scholar
156. Rumisek, JD, Albus, RA, Clarke, JS. Late Mycobacterium chelonei bio-prosthetic valve endocarditis: activation of implanted contaminant? Ann Thorac Surg 1985; 39:277–279.Google Scholar
157. Gerding, DN, Poley, BJ, Hall, WH, LeWin, DP, Clark, MD. Treatment of Pseudomonas endophthalmitis associated with prosthetic intraocular lens implantation. Am J Ophthalmol 1979; 88:902–908.Google Scholar
158. Verbraeken, H, Mendoza, A, Van Oye, R. Pseudophakie endophthalmitis. Bull Soc Beige Ophtalmol 1983; 206:55–59.Google Scholar
159. Weber, DJ, Rutala, WA. Lessons from outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol 2001; 22:403–408.Google Scholar
160. Weber, DJ, Rutala, WA, DiMarino, AJ. The prevention of infection following gastrointestinal endoscopy: the importance of prophylaxis and reprocessing. In: DiMarino, AJ, Benjamin, SB, eds. Gastrointestinal Diseases: An Endoscopic Approach. Thorofare, NJ: Slack; 2002:87–106.Google Scholar
161. Boyce, JM, Potter-Bynoe, G, Chenevert, C, King, T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997; 18:622–627.Google Scholar
162. Bonten, MJ, Hayden, MK, Nathan, C, et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348:1615–1619.Google Scholar
163. Weber, DJ, Rutala, WA. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997; 18:306–309.Google Scholar
164. Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16:459–477.Google Scholar
165. Manian, FA, Meyer, L, Jenne, J. Clostridium difficile contamination of blood pressure cuffs: a call for a closer look at gloving practices in the era of universal precautions. Infect Control Hosp Epidemiol 1996; 17:180–182.Google Scholar
166. Ruchel, R, Mergeryan, H, Boger, O, Langefeld, C, Witte, W. Outbreak of methicillin-resistant Staphylococcus aureus in a German tertiary-care hospital. Infect Control Hosp Epidemiol 1999; 20:353–355.Google Scholar
167. Layton, MC, Perez, M, Heald, P, Patterson, JE. Art outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993; 14:369–375.Google Scholar
168. Rutala, WA, Weber, DJ. Water as a reservoir of nosocomial pathogens. Infect Control Hosp Epidemiol 1997; 18:609–616.Google Scholar
169. Berrouane, YF, McNutt, L-A, Buschelman, BJ, et al. Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub. Clin Infect Dis 2000; 31:1331–1337.CrossRefGoogle Scholar
170. Chang, VT, Nelson, K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000; 31:717–722.Google Scholar
171. Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile . Clin Infect Dis 2000; 31:995–1000.Google Scholar
172. Zafar, AB, Gaydos, LA, Furlong, WB, Nguyen, MH, Mennonna, PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile . Am J Infect Control 1998; 26:588–593.Google Scholar
173. Hanna, H, Raad, I, Gonzalez, V, et al. Control of nosocomial Clostridium difficile transmission in bone marrow transplantation. Infect Control Hosp Epidemiol 2000; 21:226–228.Google Scholar
174. Rutala, WA, Weber, DJ. Surface disinfection: should we do it? J Hosp Infect 2001; 48(Suppl A):S64–S68.Google Scholar
175. Larson, E. Skin hygiene and infection prevention: more of the same or different approaches? Clin Infect Dis 1999; 29:1287–1294.Google Scholar
176. Pittet, D, Hugonnet, S, Harbarth, S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000; 356:1307–1312.Google Scholar
177. Harbarth, S, Martin, Y, Rohner, P, Henry, N, Auckenthaler, R, Pittet, D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2000; 46:43–49.Google Scholar
178. Klossner, BL, Widmer, HR, Frey, F. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Dermatology 1997; 195(Suppl 2):10–13.Google Scholar
179. Dance, DAB, Pearson, AD, Seal, DV, Lowes, JA. A hospital outbreak caused by a chlorhexidine and antibiotic-resistant Proteus mirabilis . J Hosp Infect 1987; 10:10–16.CrossRefGoogle ScholarPubMed
180. Scott, E, Bloomfield, SF, Barlow, CG. An investigation of microbial contamination in the home. J Hyg Camb 1982; 89:279–203.Google Scholar
181. Speirs, JP, Anderton, A, Anderson, JG. A study of the microbial content of the domestic kitchen. Int J Environ Health Res 1995; 5:109–122.Google Scholar
182. Josephson, KL, Rubino, JR, Pepper, IL. Characterization and qualification of bacterial pathogens and indicator organisms in household kitchens with and without the use of a disinfectant cleaner. J Appl Microbiol 1997; 83:737–750.Google Scholar
183. Rutala, WA, Weber, DJ, Barbee, SL, Gergen, MF, Sobsey, MD. Evaluation of antibiotic resistant bacteria in home kitchens and bathrooms. 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Infect Control Hosp Epidemiol 2000; 21:132.Google Scholar
184. Rusin, P, Orosz-Coughlin, P, Gerba, C. Reduction of faecal coliform, coliform and heterotrophic plate count bacteria in the household kitchen and bathroom by disinfection with hypochlorite cleaners. J Appl Microbiol 1998; 85:819–828.Google Scholar
185. Parry, SM, Salmon, RL. Sporadic STEC 0157 infection: secondary household transmission in Wales. Emerg Infect Dis 1998; 4:657–661.Google Scholar
186. Schutze, GE, Sikes, JD, Stefanova, R, Cave, MD. The home environment and salmonellosis in children. Pediatrics 1999; 103:E1.Google Scholar
187. Altekruse, SF, Cohen, ML, Swerdlow, DL. Emerging foodborne diseases. Emerg Infect Dis 1997; 3:285–293.Google Scholar
188. Mead, PS, Slutsker, L, Dietz, V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607–625.Google Scholar
189. Ward, RL, Bernstein, DI, Knowlton, DR, et al. Prevention of surface-to-human transmission of rotavirus by treatment with disinfectant spray. J Clin Microbiol 1991; 29:1991–1996.Google Scholar
190. Larson, EL. Home hygiene: a reemerging issue for the new millennium. Am J Infect Control 1999; 27(Suppl):S1–S40.Google Scholar
191. Cole, EC, Addison, RM, Rubino, JR, et al. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol 2003; 95:664–676.Google Scholar
192. Rutala, WA, Weber, DJ. Uses of inorganic hypochlorite (bleach) in health care facilities. Clin Microbiol Rev 1997; 10:597–610.Google Scholar
193. Denyer, SP, Steward, GSAB. Mechanisms of action of disinfectants. Int Biodeterior Biodegrad 1998; 41:261–268.Google Scholar
194. Jones, MV. Application of HACCP to identify hygiene risks in the home. Int Biodeterior Biodegrad 1998; 41:191–199.Google Scholar
195. Laborde, DJ, Weigle, KA, Weber, DJ, Kotch, JB. Effect of fecal contamination on diarrheal illnesses rates in day-care centers. Am J Epidemiol 1993; 138:243–255.Google Scholar
196. Russell, AD. Antibiotic and biocide resistance in bacteria: comments and conclusions. J Appl Microbiol 2002; 92(Suppl):171S–173S.Google Scholar